Discover The Value of Hope: Addressing the Burden of Ovarian Cancer in Australia, a comprehensive report developed by Deloitte Access Economics in partnership with AbbVie. This important resource shines a light on the significant impact of ovarian cancer on women, their families, and communities, highlighting the urgent need for advances in detection, treatment, and support.

Download the report here

With fewer than half of those diagnosed surviving beyond five years¹, the report calls for increased investment in research, healthcare equity, and supportive care programs. Explore key insights and actionable recommendations to help improve outcomes for women affected by one of Australia’s most challenging and least understood cancers.

''AbbVie supports ongoing collaboration to advance outcomes for women with ovarian cancer. We call on key health system stakeholders and decision makers to consider the recommendations presented in this important report.

It’s our hope that Australia can improve its relative survival rates for ovarian cancer patients and reduce the overall socioeconomic burden on women, families, carers and the broader community impacted by ovarian cancer in the future".

Nathalie McNeil, Vice President and General Manager,
AbbVie Australia & New Zealand

1. AIHW 2024, Cancer data in Australia, accessed from https://www.aihw.gov.au/reports/cancer/cancer-data-in-australia/data

AU-ONCOC-250028. November 2025